4.9 • 876 Ratings
🗓️ 7 March 2025
⏱️ 32 minutes
🔗️ Recording | iTunes | RSS
🧾️ Download transcript
Listener feedback on asymptomatic aortic stenosis (AS), transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR), coronary artery calcium (CAC), and revascularization for patients with ischemic LV dysfunction are discussed by John Mandrola, MD, in today's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Aortic Valve Intervention for Asymptomatic AS
Asymptomatic Aortic Stenosis: “Time to Act” or Not So Fast?
https://www.medscape.com/viewarticle/asymptomatic-aortic-stenosis-time-act-or-not-so-fast-2025a10005o9
EARLY TAVR: A Positive Trial That Fails to Inform Clinical Decisions
https://www.medscape.com/viewarticle/early-tavr-positive-trial-fails-inform-clinical-decisions-2024a1000kec
II CAC - Coronary Artery Calcium
III CABG, PCI or Meds for Ischemic LV Dysfunction
IV Preview
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
Click on a timestamp to play from that location
0:00.0 | You're listening to This Week in Cardiology from the heart.org, Medscape Cardiology. |
0:05.7 | This podcast is intended for health care professionals only. |
0:08.8 | Any views expressed are the presenters own and do not necessarily reflect the views of WebMD or Medscape. |
0:14.8 | Hi, everyone. |
0:16.2 | This is John Mandrola from the Heart.org Medscape Cardiology, |
0:20.1 | and this is this week in cardiology for |
0:22.8 | March 7th, 2025. This week, some listener feedback on asymptomatic aortic stenosis, Tava versus |
0:31.6 | saver, coronary artery calcium, and revascularization for patients with ischemic left ventricular dysfunction. |
0:40.9 | Two listener feedback comments today. The first is that on February 14th I misspoke about |
0:48.2 | the NOAA and Artesia trials. I said that the NOAA trial was Riveroxiband versus placebo, |
0:54.0 | but of course NOAA was Edooxiband versus placebo, but of course NOAA was edoxiband versus placebo. |
0:57.6 | Two listeners have written to me about that, and I will change the transcript, and sorry for the mistake, I was just going too fast. |
1:05.2 | The second or listener feedback is worth expanding a bit based on some new papers published in Journal American College of |
1:12.1 | Cardiology, and this is in regard to the treatment of patients with asymptomatic aortic stenosis. |
1:18.5 | I received a note this week from a doctor for whom I have the highest respect for. He was, in fact, |
1:24.7 | one of my mentors at Indiana, and he was actually instrumental in me choosing |
1:29.2 | cardiology as a career. I offer this to you because I put this person in the 99th percentile |
1:35.4 | doctors I have worked with in the past three decades. My mentor did not agree with my opposition |
1:41.4 | to operating on asymptomatic patients with severe AS. I felt the |
1:46.6 | evidentiary support for this was weak, that severe aortic stenosis is not even simple to diagnose |
1:52.8 | on echo, and a change in practice pattern would lead to even more low-risk patients getting |
1:59.1 | transcatheter aortic valve replacement or taver. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.